Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers (PARIS Study) & Biobank Pearl AAA

NCT03320408 is registered in ClinicalTrials.gov with Ron Balm as lead sponsor.

NCT NCT03320408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03320408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers (PARIS Study) & Biobank Pearl AAA
Lead sponsor
Ron Balm
Phase
Observational
Overall status
Completed
Start date
October 4, 2017
Completion date
August 4, 2023
Enrollment
790 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm, abdominal aortic aneurysm, ruptured